Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: USPTO Page 26 to be considered

To answer your question with one word...because I know you want a direct answer...yes. (:  But...IMO...I think it is a given that the J's will want to be off of the hook for the "584 as a result of a settlement.....and that we will want the J's  to remain on the hook after a settlement to put even more pressure on ARM. So, to answer you original question....depends...money talks....for the right price yes, not enough $$ means no. AIMO.

Good luck to you, me, us, and all longs.

Share
New Message
Please login to post a reply